United States · FDA National Drug Code directory
LENALIDOMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60219-1715_85e664d1-1d56-4b9b-b2a1-96b32b5b1a7e
- Product NDC
- 60219-1715
- Form
- CAPSULE
- Composition / generic term
- lenalidomide
- Labeler
- Amneal Pharmaceuticals NY LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250212
- Source listing expiry
- 20271231
Source-listed ingredients
- LENALIDOMIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 28 CAPSULE in 1 BOTTLE (60219-1715-1) · 60219-1715-1
- 100 CAPSULE in 1 BOTTLE (60219-1715-2) · 60219-1715-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →